Literature DB >> 30303245

Antiplasmodial activity and cytotoxicity, isolation of active alkaloids, and dereplication of Xylopia sericea leaves ethanol extract by UPLC-DAD-ESI-MS/MS.

Douglas Costa Gontijo1, Geraldo Célio Brandão2, Maria Fernanda Alves do Nascimento1, Alaíde Braga de Oliveira1.   

Abstract

OBJECTIVES: To assess the antiplasmodial activity of the ethanol extract of Xylopia sericea leaves, Annonaceae, often associated with antimalarial use and to perform a bioguided isolation of active compounds.
METHODS: Dereplication of ethanol extract by the UPLC-DAD-ESI-MS/MS technique allowed the identification of the major constituents, isolation and identification of alkaloids. The antiplasmodial and cytotoxic activity of the extract, fractions and isolated compounds was evaluated against the chloroquine-resistant W2 strain Plasmodium falciparum and HepG2 cells, respectively. KEY
FINDINGS: Ethanol extract showed high reduction of parasitemia as well as moderate cytotoxicity (86.5 ± 3.0% growth inhibition at 50 μg/ml and CC50 72.1 ± 5.1 μg/ml, respectively). A total of eight flavonoids were identified, and two aporphine alkaloids, anonaine and O-methylmoschatoline, were isolated. Anonaine disclosed significant antiplasmodial effect and moderate cytotoxicity (IC50 23.2 ± 2.7 μg/ml, CC50 38.3 ± 2.3 μg/ml, SI 1.6) while O-methylmoschatoline was not active against P. falciparum and showed a low cytotoxicity (33.5 ± 1.9% growth inhibition at 50 μg/ml, CC50 274.4 ± 0.5 μg/ml).
CONCLUSIONS: Characterization of Xylopia sericea leaves ethanol extract by UPLC-DAD-ESI-MS/MS as well as its antiplasmodial activity and the occurrence of anonaine and O-methylmoschatoline in this Xylopia species are reported by the first time.
© 2018 Royal Pharmaceutical Society.

Entities:  

Keywords:  zzm321990Xylopia sericeazzm321990; UPLC-DAD-ESI-MS/MS; alkaloids; antiplasmodial activity; cytotoxicity; extract dereplication; flavonoids

Mesh:

Substances:

Year:  2018        PMID: 30303245     DOI: 10.1111/jphp.13029

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  In vitro antiplasmodial activity, targeted LC-MS metabolite profiling, and identification of major natural products in the bioactive extracts of Palicourea and Psychotria species from the Amazonia and Atlantic Forest biomes, Brazil.

Authors:  Douglas Costa Gontijo; Maria Fernanda Alves do Nascimento; Hugo Vianna Silva Rody; Rodrigo Andrade Magalhães; Luciano Ferreira Margalho; Geraldo Célio Brandão; Alaíde Braga de Oliveira
Journal:  Metabolomics       Date:  2021-09-04       Impact factor: 4.290

2.  Acaricidal Activity of Annonaceae Plants for Dermanyssus gallinae (Acari: Dermanyssidae) and Metabolomic Profile by HPLC-MS/MS.

Authors:  Rafaela Barbosa Pares; Dejane Santos Alves; Luis Francisco Angeli Alves; Camila Capel Godinho; Leonardo Gobbo Neto; Tiago Tavares Ferreira; Marina Martins Nascimento; Jociani Ascari; Denilson Ferreira Oliveira
Journal:  Neotrop Entomol       Date:  2021-06-28       Impact factor: 1.434

3.  Bioguided Purification of Active Compounds from Leaves of Anadenanthera colubrina var. cebil (Griseb.) Altschul.

Authors:  Daniel Rodrigo Cavalcante de Araújo; Túlio Diego da Silva; Wolfgang Harand; Claudia Sampaio de Andrade Lima; João Paulo Ferreira Neto; Bárbara de Azevedo Ramos; Tamiris Alves Rocha; Harley da Silva Alves; Rayane Sobrinho de Sousa; Ana Paula de Oliveira; Luís Cláudio Nascimento da Silva; Jackson Roberto Guedes da Silva Almeida; Márcia Vanusa da Silva; Maria Tereza Dos Santos Correia
Journal:  Biomolecules       Date:  2019-10-08

Review 4.  Alkaloids from Plants with Antimalarial Activity: A Review of Recent Studies.

Authors:  Philip F Uzor
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-12       Impact factor: 2.629

Review 5.  Advocacy for the Medicinal Plant Artabotrys hexapetalus (Yingzhao) and Antimalarial Yingzhaosu Endoperoxides.

Authors:  Christian Bailly; Jean-Pierre Hénichart
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.